Back to results
Unknown

Real World Study of Pyrotinib in Human Epidermal Growth Factor Receptor-2 (HER2) Positive Breast Cancer

NCT04158505

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

National Cancer Center, Cancer Hospital/Chinese Academy of Medical Sciences and Peking Union Medical College

Beijing, Beijing Municipality, China

View on ClinicalTrials.gov
Real World Study of Pyrotinib in Human Epidermal Growth Factor Receptor-2 (HER2) Positive Breast Cancer — TrialFind